The DOI matches its Crossref record; 26 of the 28 references it cites were found in a registry or an index.
Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum
Open accessAbstract
Neuronal nicotinic acetylcholine receptors (nAChRs) expressed on mesostriatal dopaminergic neurons are thought to mediate several behavioral effects of nicotine, including locomotion, habit learning, and reinforcement. Using immunoprecipitation and ligand-binding techniques, we have shown that both alpha6beta2* and alpha4(nonalpha6)beta2* nAChRs are expressed in the caudate-putamen and that only alpha6* nAChRs can bind alpha-conotoxin MII and methyllycaconitine with affinities of 1.3 and 40 nm, respectively. Further studies performed on 6-hydroxydopamine-lesioned striatum led to the identification of nAChR subtypes selectively expressed on dopaminergic terminals [alpha4alpha5beta2, alpha4alpha6beta2(beta3), and alpha6beta2(beta3)], nondopaminergic neuronal structures (alpha2alpha4beta2), or both structures (alpha4beta2). The identification of the nAChRs expressed on striatal dopaminergic terminals opens up the possibility of developing selective nAChR ligands active on dopaminergic systems and associated diseases, such as Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DA neurons express heteromeric nAChRs containing the α4, α5, α6, β2, and β3 subunits in various combinations, with the predominant subtypes being α4/β2/α5 and α4/α6/ β2/β3.”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Zoli et al. 2002
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationNicotinic Receptors at the Amino Acid Level
Corringer, P., Novère, N. G. L., & Changeux, J. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.431 · Cited by 832
Role of dopamine in the behavioural actions of nicotine related to addiction
Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 698
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Self-citationEndogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585
A New α-Conotoxin Which Targets α3β2 Nicotinic Acetylcholine Receptors
Cartier, G. E., Yoshikami, D., Gray, W. R., Luo, S., Olivera, B. M., & McIntosh, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7522 · Cited by 489
Self-citationNovère, N. L., & Changeux, J. (1995) · Journal of Molecular Evolution · doi:10.1007/bf00167110 · Cited by 429
Identification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed Central · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387
Self-citationLe Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
Self-citation
Research works printed but not linked: 1
- Lindstrom J (2000) The structure of nAChRs. In: Neuronal nicotinic receptors, Handbook of experimental pharmacology, Vol 144 (Cle- menti F, Fornasari D, and Gotti C, eds), pp 101-162. Berlin: Springer.
Cited by
Sorted by citations
Items 201–300 of 410
Pocivavsek, A., Icenogle, L., & Levin, E. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0416-1 · Cited by 35
Cox, B. C., Marritt, A. M., Perry, D. C., & Kellar, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05282.x · Cited by 43
Hu, T., Yang, Z., & Li, M. D. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9800-y · Cited by 34
Capelli, A. M., Castelletti, L., Chen, Y. H., Keyl, H. V. D., Pucci, L., Oliosi, B., Salvagno, C., Bertani, B., Gotti, C., Powell, A., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01213.x · Cited by 34
Self-citationZanetti, L., d’Exaerde, A. D. K., Zanardi, A., Changeux, J., Picciotto, M. R., & Zoli, M. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0419-y · Cited by 33
Self-citationMogg, A. J., Jones, F. A., Pullar, I. A., Sharples, C. G. V., & Wonnacott, S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.013 · Cited by 34
Champtiaux, N., Kalivas, P. W., & Bardo, M. T. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.10.017 · Cited by 33
Targeting nicotine addiction: the possibility of a therapeutic vaccine
Escobar‐Chávez, J. J. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s10033 · Cited by 35
Nasehi, M. M., Mafi, F., Oryan, S., Nasri, S., & Zarrindast, M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.011 · Cited by 37
A perspective on toxicology of Conus venom peptides
Satheeshkumar, P., Senthilkumar, D., & Sundaresan, U. (2015) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60342-4 · Cited by 33
Neurobiological Links Between Nicotine Addiction and Schizophrenia
George, T. P. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_04 · Cited by 33
Ghasemi, M., & Niktarash, A. H. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0044 · Cited by 33
α9-Containing Nicotinic Receptors in Cancer
Pucci, S., Zoli, M., Clementi, F., & Gotti, C. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.805123 · Cited by 32
Self-citationMarchi, M., Grilli, M., & Pittaluga, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00089 · Cited by 32
Brown, R. W., Perna, M. K., Schaefer, T. L., & Williams, M. T. (2006) · Synapse · doi:10.1002/syn.20237 · Cited by 32
Li, X. C., Karadsheh, M. S., Jenkins, P. M., & Stitzel, J. A. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.06.010 · Cited by 32
Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine
Janhunen, S. K., & Ahtee, L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.015 · Cited by 32
Faro, L. R. F., Tak-Kim, H., Alfonso, M., & Durán, R. (2019) · Toxicology · doi:10.1016/j.tox.2019.152285 · Cited by 31
The α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2* and α3β4* Receptors
Scholze, P., & Huck, S. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.607959 · Cited by 33
The Road to Discovery of Neuronal Nicotinic Cholinergic Receptor Subtypes
Collins, A. C., Salminen, O., Marks, M. J., Whiteaker, P., & Grady, S. R. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_4 · Cited by 30
Gu, S., Matta, J. A., Davini, W. B., Dawe, G. B., Lord, B., & Bredt, D. S. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.103 · Cited by 30
Alpha6-containing nicotinic acetylcholine receptor is a highly sensitive target of alcohol
Gao, F., Chen, D., Ma, X., Sudweeks, S. N., Yorgason, J. T., Gao, M., Turner, D., Eaton, J. B., McIntosh, J. M., Lukas, R. J., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.021 · Cited by 34
Self-citationAbin‐Carriquiry, J. A., Costa, G., Urbanavicius, J., Cassels, B. K., Rebolledo-Fuentes, M., Wonnacott, S., & Dajas, F. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.013 · Cited by 29
Bos‐Veneman, N. G. P., Kuin, A., Minderaa, R. B., & Hoekstra, P. J. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181cc7cbc · Cited by 29
Neurogenetic determinants and mechanisms of addiction to nicotine and smoked tobacco
Sharp, B. M., & Chen, H. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14171 · Cited by 29
Chen, R., Ferris, M. J., & Wang, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107583 · Cited by 30
Wilkerson, J. L., Deba, F., Crowley, M. L., Hamouda, A. K., & McMahon, L. R. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108008 · Cited by 29
Greenbaum, L., Rigbi, A., Lipshtat, N., Cilia, R., Tesei, S., Asselta, R., Djaldetti, R., Goldwurm, S., & Lerer, B. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.007 · Cited by 27
Ciesla, L. M., Okine, M., Rosenberg, A., Dossou, K. S. S., Toll, L., Wainer, I. W., & Moaddel, R. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.12.065 · Cited by 27
de la Mora, M. P., Hernández-Mondragón, J. C., Crespo‐Ramírez, M., Rejón-Orantes, J. D. C., Borroto‐Escuela, D. O., & Fuxé, K. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.026 · Cited by 28
Zhu, J., Bardo, M. T., Bruntz, R. C., Stairs, D. J., & Dwoskin, L. P. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05690.x · Cited by 27
Bordia, T., Parameswaran, N., Fan, H., Langston, J., McIntosh, J. M., & Quik, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106997 · Cited by 31
Self-citationWen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 27
Visanji, N. P., Mitchell, S. N., O'Neill, M. J., & Duty, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.013 · Cited by 25
In vivo Effects of the Anatoxin-a on Striatal Dopamine Release
Campos, F., Durán, R., Vidal, L., Faro, L. R. F., & Alfonso, M. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9042-x · Cited by 25
Ray, M., Bohr, I. J., McIntosh, J. M., Ballard, C. G., McKeith, I. G., Chalon, S., Guilloteau, D., Perry, R., Perry, E. K., COURT, J. A., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.042 · Cited by 25
Self-citationGrinevich, V. P., Crooks, P. A., Sumithran, S. P., Haubner, A. J., Ayers, J. T., & Dwoskin, L. P. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051789 · Cited by 25
Grilli, M., Zappettini, S., Zoli, M., & Marchi, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05933.x · Cited by 24
Self-citationDRD2/CHRNA5 Interaction on Prefrontal Biology and Physiology during Working Memory
Giorgio, A. D., Smith, R. M., Fazio, L., D’Ambrosio, E., Gelao, B., Tomasicchio, A., Selvaggi, P., Taurisano, P., Quarto, T., Masellis, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095997 · Cited by 24
Nunes, E. J., Bitner, L. E., Hughley, S. M., Small, K. M., Walton, S. N., Rupprecht, L. E., & Addy, N. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.06.028 · Cited by 25
Wang, Y., Sherwood, J. L., Miles, C., Whiffin, G., & Lodge, D. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706621 · Cited by 23
Hussmann, G. P., DeDominicis, K. E., Turner, J. R., Yasuda, R. P., Klehm, J., Forcelli, P. A., Xiao, Y., Richardson, J. R., Sahibzada, N., Wolfe, B. B., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12653 · Cited by 23
Bordia, T., McIntosh, J. M., & Quik, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12179 · Cited by 23
Self-citationConserved Nicotine-Activated Neuroprotective Pathways Involve Mitochondrial Stress
Nourse, J. B., Harshefi, G., Marom, A. D., Karmi, A., Ben-Ami, H. C., Caldwell, K. A., Caldwell, G. A., & Treinin, M. (2020) · iScience · doi:10.1016/j.isci.2021.102140 · Cited by 23
Liu, Z., Otsu, Y., Vasuta, C., Nawa, H., & Murphy, T. H. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00768.2006 · Cited by 23
L-DOPA Treatment Modulates Nicotinic Receptors in Monkey Striatum
Quik, M., Bordia, T., Okihara, M., Fan, H., Marks, M. J., McIntosh, J. M., & Whiteaker, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.619 · Cited by 27
Self-citationNon-Motor Symptoms: The Hidden Face of Parkinson’s Disease
Cattaneo, C., Fabbrini, A., Belvisi, D., Aiello, F., Marchet, F., & Fabbrini, G. (2025) · Cells · doi:10.3390/cells15010042 · Cited by 28
You, S., Li, X., Xiong, J., Zhu, X., Zhangsun, D., Zhu, X., & Luo, S. (2019) · Marine Drugs · doi:10.3390/md17090490 · Cited by 22
Escubedo, E., Camarasa, J., Chipana, C., Garcia-Ratés, S., & Pubill, D. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)88006-9 · Cited by 23
Hone, A. J., Fisher, F. A., Christensen, S. B., Gajewiak, J., Larkin, D., Whiteaker, P., & McIntosh, J. M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00566 · Cited by 22
Self-citationThe cholinergic system in Down's syndrome
Fodale, V., Mafrica, F., Caminiti, V., & Grasso, G. (2006) · Journal of Intellectual Disabilities · doi:10.1177/1744629506067615 · Cited by 22
Grinevich, V. P., Zakirov, A. N., Berseneva, U. V., Gerasimova, E., Gainetdinov, R. R., & Budygin, E. A. (2022) · Cells · doi:10.3390/cells11091533 · Cited by 21
Dougherty, J. J., & Nichols, R. A. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.62 · Cited by 21
Matsubayashi, H., Amano, T., Seki, T., Sasa, M., & Sakai, N. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.040 · Cited by 21
Expression of cloned α6* nicotinic acetylcholine receptors
Wang, J., Kuryatov, A., & Lindstrom, J. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.009 · Cited by 21
Review: Nicotinic receptors and stages of nicotine dependence
Brennan, K., Lea, R. A., Fitzmaurice, P. S., & Truman, P. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108100256 · Cited by 22
Randall, P. A., Cannady, R., & Besheer, J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4354-2 · Cited by 18
Rose, E. J., Ross, T. J., Kurup, P. K., & Stein, E. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1788-9 · Cited by 18
Sarginson, J. E., Killen, J. D., Lazzeroni, L. C., Fortmann, S. P., Ryan, H. S., Ameli, N., Schatzberg, A. F., & Murphy, G. M. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu273 · Cited by 19
Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence
Zuo, L., Tan, Y., Li, C. R., Wang, Z., Wang, K., Zhang, X., Lin, X., Chen, X., Zhong, C., Wang, X., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32476 · Cited by 18
α7 but not α4 AChR subunit expression is regulated by light in developing primary visual cortex
Aztiria, E., Gotti, C., & Domenici, L. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20358 · Cited by 18
Self-citationQuik, M., Campos, C., Parameswaran, N., Langston, J. W., McIntosh, J. M., & Yeluashvili, M. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9265-9 · Cited by 18
Self-citationMetaxas, A., Keyworth, H. L., Yoo, J.-S., Chen, Y., Kitchen, I., & Bailey, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02023.x · Cited by 18
Abdrakhmanova, G. R., Damaj, M. I., Carroll, F. I., & Martin, B. R. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021782 · Cited by 18
Jiang, J. W., Li, X., Hu, A., Zhou, G., Gao, Y.-H., Xu, C., Wu, X., & Wang, H. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1670883 · Cited by 24
Garção, P., Oliveira, C. R., Cunha, R. A., & Agostinho, P. M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.02.018 · Cited by 17
Gözen, O., Nesil, T., Kanıt, L., Koylu, E. O., & Pöğün, Ş. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1198799 · Cited by 17
O’Leary, K. T., Loughlin, S. E., Chen, Y.-L., & Leslie, F. M. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21833 · Cited by 17
Wadsworth, H. A., Anderson, E. Q., Williams, B. M., Ronström, J. W., Moen, J. K., Lee, A. M., McIntosh, J. M., Wu, J., Yorgason, J. T., & Steffensen, S. C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03263-5 · Cited by 17
Self-citationJanhunen, S. K., Mielikäinen, P., Paldánius, P. M., Tuominen, R. K., Ahtee, L., & Kaakkola, S. (2005) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-005-1066-2 · Cited by 16
McGuirt, A. F., Lieberman, O. J., Post, M., Pigulevskiy, I., & Sulzer, D. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0755-20.2021 · Cited by 17
Hussmann, G. P., Yasuda, R. P., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289546 · Cited by 16
Zhu, X.-P., Wang, S., Kaas, Q., Yu, J.-P., Wu, Y., Harvey, P., Zhangsun, D.-T., Craik, D., & Luo, S.-L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01786 · Cited by 14
Hoestgaard-Jensen, K., Hoestgaard-Jensen, K., & Jensen, A. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.509356 · Cited by 15
Hamouda, A. K., Bautista, M. R., Akinola, L. S., Alkhlaif, Y., Jackson, A. B., Carper, M., Toma, W. B., Garai, S., Chen, Y.-C., Thakur, G. A., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108568 · Cited by 15
Seddik, R., Schlichter, R., & Trouslard, J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.007 · Cited by 15
Methadone’s effect on nAChRs—a link between methadone use and smoking?
Talka, R., Tuominen, R. K., & Salminen, O. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.031 · Cited by 15
Sidhpura, N., Redfern, P. H., & Wonnacott, S. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.052 · Cited by 14
Eggan, B. L., & McCallum, S. E. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.04.008 · Cited by 14
Kutschenko, A., Staege, S., Grütz, K., Glaß, H., Kalmbach, N., Gschwendtberger, T., Henkel, L. M., Heine, J., Grünewald, A., Hermann, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073565 · Cited by 14
Chronic nicotine treatment increases GABAergic input to striatal neurons
Miura, M., Ishii, K., Aosaki, T., & Sumikawa, K. (2006) · Neuroreport · doi:10.1097/01.wnr.0000204984.21748.e3 · Cited by 14
Li, W., Han, H., Liu, Q., Su, K., Yang, Z., Cui, W., Yuan, W., Ma, Y., Fan, R., Chen, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09492-8 · Cited by 15
Nicotinic Acetylcholine Receptors of PC12 Cells
Mussina, K., Toktarkhanova, D., & Filchakova, O. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00846-x · Cited by 15
Brain Nicotinic Receptors as Emerging Targets for Drug Addiction
Rahman, S. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00008-9 · Cited by 14
Kucinski, A., Wersinger, S., Stachowiak, E., Corso, T. D., Parry, M., Zhang, J., Jordan, K., Letchworth, S., Bencherif, M., & Stachowiak, M. (2013) · Pharmacology, Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.005 · Cited by 13
Nicotine Increases Spontaneous Glutamate Release in the Rostromedial Tegmental Nucleus
Castillo-Rolón, D., Ramírez-Sánchez, E., Arenas-López, G., Garduño, J., Hernández-González, O., Mihailescu, S., & Hernández‐López, S. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.604583 · Cited by 12
CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking
Bar‐Shira, A., Gana‐Weisz, M., Gan‐Or, Z., Giladi, E., Giladi, N., & Orr‐Urtreger, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.014 · Cited by 13
Evidence for the role of β2* nAChR desensitization in regulating body weight in obese mice
Dezfuli, G., Kellar, K. J., Dretchen, K. L., Tizabi, Y., Sahibzada, N., & Gillis, R. A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.020 · Cited by 13
Matera, C., Pucci, L., Fiorentini, C., Fucile, S., Missale, C., Grazioso, G., Clementi, F., Zoli, M., Amici, M. D., Gotti, C., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.039 · Cited by 13
Self-citationNagai, T., Nabeshima, T., & Yamada, K. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r04fm · Cited by 14
Motor deficits and altered striatal gene expression in aphakia (ak) mice
Singh, B., Wilson, J. H., Vasavada, H. H., Guo, Z., Allore, H. G., & Zeiss, C. J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.006 · Cited by 13
Extrinsic and intrinsic control of striatal cholinergic interneuron activity
Ratna, D., & Francis, T. C. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1528419 · Cited by 13
Yin, C., Gui, L., Du, T., Zhang, C.-J., Wei, X., Yang, J., Huang, M., Fu, B., Gong, P., Liang, J., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00782 · Cited by 12
Gahring, L. C., & Rogers, S. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105346 · Cited by 12
Acetylcholine Receptor Structure
Lindstrom, J. M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-341-5_2 · Cited by 15
Cholinergic modulation of dopamine release drives effortful behaviour
Touponse, G. C., Pomrenze, M. B., Yassine, T. A., Denomme, N., WANG, M. C., Mehta, V., Zhang, Z., Malenka, R. C., & Eshel, N. (2026) · Nature · doi:10.1038/s41586-025-10046-6 · Cited by 33
Cardé, N. A. Q., Shaw, J. K., Carter, C., Kim, S., Stitzel, J. A., Venkatesh, S. K., Ramchandani, V. A., & Biasi, M. D. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109170 · Cited by 10
McClure‐Begley, T. D., Wageman, C. R., Grady, S. R., Marks, M. J., McIntosh, J. M., Collins, A. C., & Whiteaker, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07759.x · Cited by 11
Self-citationDwoskin, L. P., Pivavarchyk, M., Joyce, B. M., Neugebauer, N. M., Zheng, G., Zhang, Z., Bardo, M. T., & Crooks, P. A. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_4 · Cited by 12
Nie, H.-Z., Li, Z.-Q., Lukas, R., Shen, Y.-H., Song, L., Wang, X., & Yin, M. (2007) · Cellular and molecular neurobiology · doi:10.1007/s10571-007-9218-1 · Cited by 11
Metadata
- Authors
- Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C.
- Affiliations
- University of Milan (IT)
- University of Modena and Reggio Emilia (IT)
- University of Utah (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-10-15
- Volume
- 22
- Issue
- 20
- Pages
- 8785-8789
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6757689
- OpenAlex
- W2162000418
- Cited by
- 407
- References
- 28
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 11 · 2020: 10 · 2019: 13 · 2018: 15 · 2017: 9 · 2016: 16 · 2015: 13 · 2014: 16 · 2013: 10 · 2012: 14
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, dopaminergic terminals, striatum, caudate-putamen, alpha4beta2 nAChR, alpha-conotoxin MII, methyllycaconitine, nicotine, 6-hydroxydopamine lesion, Parkinson's disease
- MeSH terms
- Animals, Binding, Competitive, Corpus Striatum, Dopamine, Ligands, Male, Precipitin Tests, Receptors, Nicotinic, Specific Pathogen-Free Organisms, Oxidopamine, Rats, Sprague-Dawley, Presynaptic Terminals, Nicotinic Agonists, Nicotinic Antagonists, Dopamine Uptake Inhibitors, Protein Subunits, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review